January 29, 2016

High cost of specialty drugs makes adherence to therapy more important than ever

WOONSOCKET, R.I., (January 29, 2016) – New research published by the CVS Health (NYSE: CVS) Research Institute showed a significant improvement in adherence to specialty medications for patients enrolled in a pilot study evaluating Specialty Connect™, CVS Health’s innovative specialty prescription services program. New patients enrolled in the pilot were 17.5 percent more likely to pick up their first refill and existing specialty patients had an 11.4 percentage point improvement in adherence, as compared to a control group. The study was published in the most recent issue of the Journal of the American Pharmacists Association. (more…)